Folate Receptor Autoantibodies and Spinal Fluid 5-Methyltetrahydrofolate Defi ciency in Rett Syndrome
Serum FR autoantibodies of the blocking type have been associated with the infantile-onset CFD syndrome whereas in age-matched controls and in serum from subjects with central nervous system disease unrelated to cerebral folate deficiency these FR autoantibodies were absent. In vitro studies substantiated the blocking action of these FR autoantibodies that form a complex with the FR at its folate-binding site and thus impairs the binding of 5-methyltetrahydrofolate (5MTHF) to the FR [5] . Recent studies now have confi rmed an inverse correlation between the titer of the serum FR autoantibodies and the CSF 5MTHF levels (unpublished results). In order to explain the low CSF folate in 42 -50 % of Rett patients due to reduced folate transport into the CNS, serum samples from all study participants were analysed for blocking autoantibodies against the folate receptors (FRs).
Introduction &
After intestinal absorption of food-derived folates, intestinal cells will convert folate compounds to 5MTHF, which represents the predominant and only reduced folate form in plasma which is able to cross the blood-brain barrier. Plasma 5MTHF is actively transported into the spinal fl uid compartment by folate receptor (FR) endocytosis at choroid epithelial cells. Approximately 42-50% of Rett patients from Europe and Israel were previously reported to have a reduced concentration of 5-methyltetrahydrofolate (5MTHF) in the cerebrospinal fl uid (CSF) [1 -3] . Oral folinic acid supplementation restored 5MTHF levels in the spinal fl uid with partial clinical improvement and better seizure control [1, 3] . The reduced folate in the CSF could not be attributed to abnormalities of the FR1 or FR2 genes and was independent of methyl-CpG binding protein (MECP2) status [1] . A recent study from North America reported that only 2 of 76 female Rett patients had a low spinal fl uid 5MTHF level [4] . a classical Rett phenotype were selected for this study [6] . Complete genetic analysis of the MECP2 gene revealed abnormalities in 21 of the 33 patients. Epileptic seizures were found in 15 of 33 Rett patients, for which anticonvulsant drugs were administered. All patients whose serum and red blood cell folate levels were normal, underwent a spinal tap to determine the concentration of 5MTHF in the CSF. Eight girls with Rett syndrome lived in North-Western Europe (patient 1 -6 in Germany; patient 7,8 in Belgium), while 25 patients resided in Southern Europe (patients 9 -19 in Spain; patients 20 -33 in Portugal)( ᭹ ᭤ Table 1 ). Age-related references for 5MTHF in the CSF have been established for both populations from North-Western and South-Western Europe [5, 7] .
To determine the cause of reduced 5MTHF in the CSF, serum samples were analyzed for the presence of blocking autoantibodies against the FRs using previously reported methods [5] . Statistical analysis used the Fisher exact test to compare the incidence of low CSF folate and FR autoimmunity among the two groups from North-Western and South-Western Europe, and to study the association of FR autoimmunity with CSF folate status.
The Fisher exact test was also applied to compare the incidence of cerebral folate defi ciency (CFD) between Rett patients from Europe and North-America, and to determine the incidence of FR autoantibodies in Rett patients in Europe and healthy controls. Statistical analysis used the analysis of variance for independent samples to compare the serum and CSF folate values between the European Rett population, North-American Rett population and healthy controls. The analysis of variance was also used to compare the CSF folate levels between Rett girls residing in North-Western, South-Western parts of Europe and healthy controls. Data have been used from a study on North-American Rett girls and from the available data on serum folate extracted from the American National Health and Nutrition Examination Survey 1999 -2000 [4, 8] .
Results &
Compared to North-American Rett patients and healthy European controls, the 33 Rett girls from Europe had a statistically Table 2 ). In 14 European Rett patients (10 subjects with MECP2 gene abnormalities and 4 with a normal genotype), the concentration of 5MTHF in the CSF was below the lower reference limit of healthy controls ( ᭹ ᭤ Table 3 ) with a calculated Fisher exact probability at p = 0.005 and p = 0.037 respectively. ) using the analysis of variance for three independent samples (F = 7.62 and p = 0.000802). Serum folate levels from healthy North-American girls were also signifi cantly higher than healthy European controls ( ᭹ ᭤ Table 2 ). 
Discussion &
We have identifi ed autoantibodies against the FRs in 24 % of 33 Rett patients from Europe. This fi nding suggests a mechanism for the low CSF concentration of 5MTHF and the accompanying CFD-like features in these Rett patients. In contrast, a subgroup of Rett patients with low CSF folate and most Rett patients with normal CSF folate levels lack these autoantibodies. Furthermore, two Rett patients with low titers of autoantibodies had normal CSF folates (patients 15,26). Our study also showed a higher incidence of CFD and FR autoimmunity among the group of Rett patients residing in North-Western Europe, when compared to those living in Southern Europe. The lowest CSF folate values associated with FR autoantibodies were found in the Rett patients living in Northern Europe. It is likely that Rett syndrome patients with these autoantibodies in their serum cannot transfer the 5MTHF into the CSF because the autoantibodies block the binding of folate to the FR expressed on the choroid plexus and thereby prevent the transfer of folate to the CNS. Our previous study showed that the CSF of Rett patients with low folate contained a normal concentration of immunoreactive folate receptor protein that did not bind radiolabelled folate [1, 2] . These soluble non-functional FR proteins in CSF could represent autoantibody-FR complexes released into the spinal fl uid after cleavage from their GPIanchor attachment to the choroid plexus epithelial membranes. Our observation of circulating FR autoantibodies of the blocking type in three patients with a Rett phenotype, low CSF folate and a normal MECP2 genotype may point to a variant of the classical Rett phenotype that presents as a CFD-like syndrome. However, the fi nding of low CSF folate in 1 of the Rett patients with a normal MECP2 genotype and absence of FR autoimmunity suggests that other unknown aetiologies can contribute to the low CSF folate status in the Rett phenotype. The geographical differences for FR autoimmunity and CFD between North-Western and South-Western Europe may be explained by nutritional differences with the higher consumption of milk and milk products in Northern Europe. Bovine FR has high amino acid sequence homology with the human FR [9] and may be the source of the antigen. Cross-reactivity of the antibodies generated against the soluble bovine FR with the human FR antigen may provide a basis of our hypothesis on FR autoimmunity, which was proposed as a possible mechanism for the observed FR autoimmunity in children with the infantile-onset CFD syndrome [5] . The lower incidence of cerebral folate deficiency in the Rett population of North America may be explained by the folate food fortifi cation and the folate / betaine trial, where the participants stopped folate at least 30 days or 1 week prior to lumbar puncture [4] . After folate is incorporated into cells, it takes more than 90 days before these folate reserves decrease [10] . Therefore, if folate supplementation is interrupted for less than 100 days before a lumbar puncture, the results have to be interpreted with caution. Comparison of the data from America and Europe has confi rmed the signifi cantly higher serum and CSF folate levels present in the American Rett population. A comparison of the incidence of the FR autoantibodies in the two patient populations from both continents would be an interesting issue to address in order to explain these confl icting results. Our fi nding of low CSF folate in 42 % of Rett patients suggests that folate transport across the choroid plexus may be blocked. The presence of serum FR autoantibodies in some of these patients provides an explanation for their low CSF 5MTHF. However, in Rett patients where the CSF / plasma folate ratio remains normal other mechanisms such as an increased folate turnover due to an increased utilization or catabolism of 5MTHF or other metabolic abnormalities have to be considered [10] . 
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